BEIJING, Dec. 2, 2019 /PRNewswire/ -- Concord Medical
Services Holdings Limited ("Concord Medical" or the "Company")
(NYSE: CCM), a specialty hospital management group and an operator
of the network of radiotherapy and diagnostic imaging centers in
China, today announced the
resignation of Mr. Shang Yan Chuang
as director of the Company. Mr. Chuang submitted his resignation to
the Board for personal reasons.
In addition, Concord Medical's board of directors has accepted
Mr. Chuang's resignation and appointed Mr. Qing Pan as a director
of the Company, effective from November 29,
2019.
Mr. Qing Pan is the CFO of Noah Holdings Limited ("Noah"). As a
veteran in the investment and finance community, Mr. Pan spent 17
years with Deloitte as an audit partner before joining Noah. He was
also a former member of the accounting research division at
Deloitte's headquarter in the US. He led several Chinese companies'
US listings across various industries. Mr. Pan received an MBA and
a master degree in science from Northeastern
University in Boston, U.S.,
in 1999. Mr. Pan is certified in public accounting in the U.S.,
mainland China and Hong Kong.
Dr. Jianyu Yang, Chairman and
CEO, commented, "We are very pleased to welcome Mr. Pan to the
Board. Mr. Pan's experience will be invaluable to our growth and we
believe he will make significant contributions to the Company. I
would also like to express my gratitude to Mr. Chuang for his
contributions to the Company over the past years. He has
contributed to our development and we wish him success in the
future endeavors."
About Concord Medical
Concord Medical Services Holdings Limited is a specialty
hospital management group, including premium cancer hospitals and
international hospitals with multi-disciplinary treatment featuring
proton therapy, as well as secondary specialty cancer hospitals and
independent medical institutions, and an operator of the network of
radiotherapy and diagnostic imaging centers in China. As of June 30,
2019, the Company operated a network of 30 centers based in
20 hospitals, spanning over 20 cities across 13 provinces and
administrative regions in China.
Under long-term arrangements with top-tier hospitals in
China, the Company provides
radiotherapy and diagnostic imaging equipment and manages the daily
operations of these centers, which are located on the premises of
its hospital partners. The Company also provides ongoing training
to doctors and other medical professionals in its network of
centers to ensure a high level of clinical care for patients. For
more information, please see http://ir.ccm.cn.
View original
content:http://www.prnewswire.com/news-releases/concord-medical-announces-changes-to-the-board-300967233.html
SOURCE Concord Medical Services Holdings Limited